Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001070227 | SCV001235445 | pathogenic | Alstrom syndrome | 2023-11-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser697*) in the ALMS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALMS1 are known to be pathogenic (PMID: 17594715). This variant is present in population databases (no rsID available, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with Alstrom syndrome (PMID: 24049434, 26047050). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Ser695*. ClinVar contains an entry for this variant (Variation ID: 863290). For these reasons, this variant has been classified as Pathogenic. |
Natera, |
RCV001070227 | SCV002080442 | pathogenic | Alstrom syndrome | 2020-07-13 | no assertion criteria provided | clinical testing |